We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KE:NASDAQKimball Electronics, Inc. Analysis

Data as of 2026-04-12 - not real-time

$25.94

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kimball Electronics is trading near a key resistance level while sitting below both its short‑term and mid‑term moving averages, signaling a bearish price bias. The MACD histogram is positive and the signal line is in bullish territory, suggesting some underlying momentum, but the overall trend direction remains bearish and volume has been tapering, hinting at weakening participation. Relative strength is approaching the upper mid‑range, indicating the stock is not yet oversold, yet high 30‑day volatility and a beta well above the market underscore pronounced price swings. Market sentiment is in the extreme greed zone, which may be inflating short‑term demand despite the technical downside. Fundamentally, the company’s price is well under its discounted cash‑flow estimate, offering a sizable upside buffer, while its price‑to‑earnings multiple trails the industry average, reinforcing a value case. Recent participation in investor conferences and the release of a comprehensive sustainability report highlight a proactive approach to stakeholder engagement and ESG integration, which could bolster longer‑term perception and demand.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price hovering near resistance with a bearish trend
  • declining volume and high volatility
  • MACD showing mixed signals

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • stock priced below DCF fair value with upside potential
  • valuation multiples lower than peers
  • enhanced market visibility from investor events and sustainability focus

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • diversified global footprint in high‑growth EMS markets
  • ongoing ESG initiatives that may improve stakeholder confidence
  • solid cash flow generation despite thin margins

Key Metrics & Analysis

Financial Health

Revenue Growth-4.50%
Profit Margin1.65%
P/E Ratio26.7
ROE4.32%
ROA3.63%
Debt/Equity29.52
P/B Ratio1.1
Op. Cash Flow$123.9M
Free Cash Flow$77.1M
Industry P/E30.9

Technical Analysis

TrendBearish
RSI59.8
Support$22.32
Resistance$26.01
MA 20$24.22
MA 50$24.99
MA 200$26.43
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09

Valuation

Fair Value$39.09
Target Price$33.00
Upside/Downside27.22%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.74
Volatility43.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.